GLP-1 receptor agonists are everywhere right now. They’re talked about on social media, in exam rooms, and at dinner tables. But they aren’t new. This class of medications was originally developed to treat diabetes. GLP-1 stands for glucagon-like peptide-1 . I like to think of it as a key. And the GLP-1 receptors? Those are the locks. These locks live all over the body—in the brain, the pancreas, the heart, and the gastrointestinal tract. When the key fits into the lock, a fe

In the 1980s, the explanation for obesity was simple: overconsumption and inactivity. And to be fair, that wasn’t wrong. But it also wasn’t the whole story. Obesity is far more complex than “eat less, move more.” Most of the time, it’s the result of multiple factors working together—many of them outside a person’s control. Let’s talk about a few. A conceptual illustration highlighting the diverse factors contributing to obesity, featuring a silhouette of a pregnant woman surr